Our Vision
We envision a future where cancer is no longer a grim diagnosis because treatments exist that eliminate it at the source, and cures come without the severe systemic side effects of current-day immuno-oncology therapies.
Our Approach
We are using our proprietary platform technology to design and develop tumor-activated immuno-oncology therapies that have the potential to provide effective, tolerable, and durable therapeutic options for patients with solid tumors. We are building a pipeline of novel, tumor-activated molecules, including antibodies, cytokines, bispecifics and cell engagers, that are designed to optimize their therapeutic index and localize anti-tumor activity within the tumor microenvironment. Click on the links below to learn more:
